Cudurka Alzheimers waxaa lagu ogaadaa habab kala duwan, oo ay ku jiraan qiimeyn caafimaad oo dhameystiran, tijaabooyin garasho iyo neuropsychological ah, sawir qaadista maskaxda, iyo habka looga takhaluso sababaha kale ee suurtagalka ah.
1. Baadhitaan caafimaad: Dhakhtarku wuxuu sameynayaa baaritaan jireed wuxuuna qaadanayaa taariikh caafimaad oo faahfaahsan si uu uga fogaado sababaha kale ee suurtagalka ah ee xusuusta luminta ama hoos u dhaca garashada, sida dhibaatooyinka qanjirka 'thyroid', yaraanta fitamiinada, ama burooyinka maskaxda.
2. Tijaabooyinka garashada iyo neuropsychological: Tijaabooyinkan waxay qiimeeyaan xusuusta, luqadda, xallinta dhibaatooyinka, iyo shaqooyinka kale ee garashada si loo go'aamiyo baaxadda cilladda garashada iyo in la kala saaro luminta xusuusta caadiga ah ee da'da la xiriirta iyo waallida.
3. Sawirka maskaxda: Sawirka magnetic resonance (MRI) ama sawirka kumbuyuutarka (CT) waxay kaa caawin karaan inaad ogaato isbeddelada qaab dhismeedka maskaxda ee muujin kara cudurka Alzheimer.
Baaritaanka Positron emission tomography (PET) waxaa sidoo kale loo isticmaali karaa in lagu cabbiro heerarka borotiinka qaarkood ee la xiriira cudurka Alzheimer.
4. Baaritaanada dhiigga: Cilmi baaris dhowaan la sameeyay ayaa muujisay in baaritaanada dhiigga qaarkood ay ka caawin karaan ogaanshaha cudurka Alzheimers iyadoo la cabbiro heerarka borotiinka gaarka ah ama calaamadaha noolaha ee la xiriira cudurka.
5. Nidaamka baabi'inta: Maadaama aysan jirin hal baaritaan oo dhab ah oo lagu ogaan karo cudurka Alzheimer, baaritaanka waxaa inta badan ku lug leh in la baabi'iyo sababaha kale ee suurtagalka ah ee calaamadaha waallida la midka ah.
Waxaa muhiim ah in la ogaado in cudurka Alzheimers si dhab ah loo ogaan karo dhimashada ka dib marka la baaro unugyada maskaxda.
Si kastaba ha noqotee, hababka baaritaanka ee hadda jira waxay bixin karaan heer sare oo hubaal ah oo ku saabsan baaritaanka kiliinikada inta uu qofku weli nool yahay.
Baaritaanka hore wuxuu muhiim u yahay bilowga daaweynta iyo qorshaynta mustaqbalka.
Liu SS, Zhu SQ: [Correlation between Alzheimer disease and cataract]. Zhonghua Yan Ke Za Zhi. 2017, 53 (4): 314-316.
Gauthier S: Practical guidelines for the antemortem diagnosis of senile dementia of the Alzheimer type. Prog Neuropsychopharmacol Biol Psychiatry. 1985, 9 (5-6): 491-5.
Rubin R: New Test to Help Diagnose Alzheimer Disease. JAMA. 2022, 327 (23): 2281.
[Blood Based Biomarker for Optimization of Early and Differential Diagnosis of Alzheimer's Dementia]. Fortschr Neurol Psychiatr. 2022, 90 (7-08): 326-335.
Kapp MB: Physicians' legal duties regarding the use of genetic tests to predict and diagnose Alzheimer disease. J Leg Med. 2000, 21 (4): 445-75.
Britschgi M, Wyss-Coray T: Blood protein signature for the early diagnosis of Alzheimer disease. Arch Neurol. 2009, 66 (2): 161-5.
Volicer L, Berman SA, Cipolloni PB, Mandell A: Persistent vegetative state in Alzheimer disease. Does it exist? Arch Neurol. 1997, 54 (11): 1382-4.
Imabayashi E, Saitoh Y, Tsukamoto T, Sakata M, Takano H: Combination of Astrogliosis and Phosphorylated Tau for the Preclinical Diagnosis of Alzheimer Disease Using 3-Dimensional Stereotactic Surface Projection Images With 18 F-THK5351. Clin Nucl Med. 2022, 47 (12): 1066-1068.
Martínez A, Lahiri DK, Giacobini E, Greig NH: Advances in Alzheimer therapy: understanding pharmacological approaches to the disease. Curr Alzheimer Res. 2009, 6 (2): 83-5.
Diidmada masuuliyada: caafimaadka
Boggan waxaa loogu talagalay ujeedooyin waxbarasho iyo macluumaad oo keliya mana aha bixinta talo caafimaad ama adeegyo xirfadeed.
Macluumaadka la bixiyo waa in aan loo isticmaalin in lagu ogaado ama lagu daweeyo dhibaato caafimaad ama cudur, kuwa raadinaya talo caafimaad oo shaqsiyeed waa inay la tashadaan dhakhtar ruqsad haysta.
Fadlan la soco in shabakada neerfaha ee soo saarta jawaabaha su'aalaha, ay tahay mid aan sax ahayn marka ay timaado waxyaabaha tirooyinka ah. Tusaale ahaan, tirada dadka la ogaaday inay qabaan cudur gaar ah.
Had iyo jeer raadi talada dhakhtarkaaga ama daryeel caafimaad oo kale oo u qalma oo ku saabsan xaalad caafimaad. Waligaa ha iska indho tirin talada caafimaadka xirfadeed ama ha dib u dhigin raadinta sababtoo ah wax aad ka akhrisay boggan internetka. Haddii aad u maleyneyso inaad leedahay xaalad caafimaad oo degdeg ah, wac 911 ama u tag qolka gurmadka degdegga ah ee kuugu dhow isla markiiba. Xiriirka dhakhtarka iyo bukaanka looma abuuro boggan internetka ama isticmaalkiisa. BioMedLib ama shaqaalaheeda, ama qof kasta oo ka qaybqaata boggan internetka, ma sameeyaan wax matalaad ah, si cad ama si macquul ah, oo ku saabsan macluumaadka halkan lagu bixiyo ama isticmaalkiisa.
Ogaysiiska: Xuquuqda daabacaadda
Sharciga Xuquuqda daabacaadda ee Digital Millennium ee 1998, 17 U.S.C. § 512 (the DMCA) wuxuu bixiyaa gurmad milkiilayaasha xuquuqda daabacaadda ee aaminsan in waxyaabaha ka muuqda Internetka ay ku xadgudbayaan xuquuqdooda sharciga xuquuqda daabacaadda ee Mareykanka.
Haddii aad si wanaagsan u aaminsan tahay in wax ka mid ah waxyaabaha ku jira boggeena internetka ama adeegyadeena ay ku xadgudbayaan xuquuqdaada daabacaadda, adiga (ama wakiilkaaga) ayaa noo soo diri kara ogeysiis codsanaya in waxyaabaha ku jira ama waxyaabaha laga saaro, ama la xakameeyo helitaanka.
Ogeysiisyada waa in lagu diraa qoraal ahaan emayl (eeg qaybta "Contact" ee cinwaanka emaylka).
DMCA waxay u baahan tahay in ogeysiiskaaga ku saabsan xadgudubka xuquuqda daabacaadda ee la sheegay uu ku jiro macluumaadka soo socda: (1) sharaxaadda shaqada xuquuqda daabacaadda ee ay ku saabsan tahay xadgudubka la sheegay; (2) sharaxaadda nuxurka xadgudubka la sheegay iyo macluumaadka ku filan ee noo oggolaanaya inaan helno nuxurka; (3) macluumaadkaaga xiriirka adiga, oo ay ku jiraan cinwaankaaga, lambarka taleefanka iyo cinwaanka emaylkaaga; (4) bayaan aad ku leedahay aaminaad wanaagsan oo ah in nuxurka habka lagu cabiray uusan oggolaan milkiilaha xuquuqda daabacaadda, ama wakiilkiisa, ama hawlgalka sharci kasta;
(5) bayaan aad saxiixday oo aad ku cadeyneyso in macluumaadka ku jira ogeysiiska uu sax yahay iyo in aad awood u leedahay in aad dhaqan geliso xuquuqda daabacaadda ee la sheeganayo in la jabiyay;
iyo (6) saxiix jireed ama elektaroonig ah oo ka yimid milkiilaha xuquuqda daabacaadda ama qof loo oggol yahay inuu ku dhaqmo magaca milkiilaha xuquuqda daabacaadda.
Haddii aadan ku darin dhammaan macluumaadka kor ku xusan waxay keeni kartaa dib u dhac ku yimaada ka baaraandegista cabashadaada.
Xiriirka
Fadlan noogu soo dir emayl su'aal kasta / soo jeedin.
How is alzheimer diagnosed?
Alzheimer's disease is diagnosed through a combination of methods, including a thorough medical evaluation, cognitive and neuropsychological tests, brain imaging, and the process of elimination of other possible causes.
1. Medical evaluation: A doctor will perform a physical examination and take a detailed medical history to rule out other possible causes of memory loss or cognitive decline, such as thyroid problems, vitamin deficiencies, or brain tumors.
2. Cognitive and neuropsychological tests: These tests assess memory, language, problem-solving, and other cognitive functions to determine the extent of cognitive impairment and to differentiate between normal age-related memory loss and dementia.
3. Brain imaging: Magnetic resonance imaging (MRI) or computed tomography (CT) scans can help identify structural changes in the brain that may indicate Alzheimer's disease.
Positron emission tomography (PET) scans can also be used to measure the levels of certain proteins associated with Alzheimer's disease.
4. Blood tests: Recent research has shown that certain blood tests can help diagnose Alzheimer's disease by measuring the levels of specific proteins or biomarkers associated with the disease.
5. Process of elimination: Since there is no single definitive test for Alzheimer's disease, diagnosis often involves ruling out other possible causes of dementia-like symptoms.
It is important to note that a definitive diagnosis of Alzheimer's disease can only be made after death through an examination of brain tissue.
However, current diagnostic methods can provide a high level of certainty for a clinical diagnosis while the person is still alive.
Early diagnosis is important for starting treatment and planning for the future.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Qiyaastii
BioMedLib waxay isticmaashaa kumbuyuutaro otomaatig ah (algorithms-ka barashada mashiinka) si ay u soo saaraan laba su'aalood iyo jawaabo.
Waxaan ka bilownay 35 milyan oo daabacaadyo caafimaad oo ku saabsan PubMed/Medline. Sidoo kale, bogagga RefinedWeb.
Eeg "Tixraacyada" sidoo kale "Qeexitaanka mas'uuliyadda".
